<code id='892DFBBD8B'></code><style id='892DFBBD8B'></style>

<acronym id='892DFBBD8B'></acronym>

<center id='892DFBBD8B'><center id='892DFBBD8B'><tfoot id='892DFBBD8B'></tfoot></center><abbr id='892DFBBD8B'><dir id='892DFBBD8B'><tfoot id='892DFBBD8B'></tfoot><noframes id='892DFBBD8B'>

<optgroup id='892DFBBD8B'><strike id='892DFBBD8B'><sup id='892DFBBD8B'></sup></strike><code id='892DFBBD8B'></code></optgroup>

<b id='892DFBBD8B'><label id='892DFBBD8B'><select id='892DFBBD8B'><dt id='892DFBBD8B'><span id='892DFBBD8B'></span></dt></select></label></b><u id='892DFBBD8B'></u>

~~<i id='892DFBBD8B'><strike id='892DFBBD8B'><tt id='892DFBBD8B'><pre id='892DFBBD8B'></pre></tt></strike></i>~~

Home» explore» knowledge

knowledge

knowledge

author：hotspot 2025-09-30 04:23:47 Page View：3

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

advertisement

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novo: Oral version of Ozempic leads to 15% weight loss
Next article： George Santos makes 1st court appearance after pleading not guilty to 13 counts

comprehensive

Bright Health sells Medicare Advantage business to Molina

Bright Health sells Medicare Advantage business to Molina

BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

VictorSeguraIbarraandRitaSerda,Ph.D.,NCI,NIHTheFoodandDrugAdministrationonWednesdayapprovedafuturist

State Dept. review finds Biden bears some blame for Afghanistan failures

State Dept. review finds Biden bears some blame for Afghanistan failures

3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

3:41SulemanDawoodandShahzadaDawoodDawoodFamilyThefamilyoftwovictimsfromthesubmersiblethatimplodednea

read more